BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2688978)

  • 1. The interaction between diltiazem and left ventricular function after myocardial infarction. Multicenter Diltiazem Post-Infarction Research Group.
    Moss AJ; Oakes D; Benhorin J; Carleen E
    Circulation; 1989 Dec; 80(6 Suppl):IV102-6. PubMed ID: 2688978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Improvement of postinfarct left myocardial contractile function after administration of diltiazem].
    Gambelli G; Donati R; Mezzanotte R; Pozzar F; Cesario AS; Schiavo B; Pau F
    G Ital Cardiol; 1998 Mar; 28(3):249-58. PubMed ID: 9561879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
    Dai SM; Zhang S; Chen KP; Hua W; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Apr; 122(7):802-6. PubMed ID: 19493393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.
    Gibson RS; Boden WE; Theroux P; Strauss HD; Pratt CM; Gheorghiade M; Capone RJ; Crawford MH; Schlant RC; Kleiger RE
    N Engl J Med; 1986 Aug; 315(7):423-9. PubMed ID: 3526151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemodynamic effects of diltiazem in the subacute stage of myocardial infarct treated by thrombolysis].
    Terrosu P; Ibba GV; Contini GM; Franceschino V; Delpini A; Pes R
    G Ital Cardiol; 1987 May; 17(5):450-5. PubMed ID: 3653603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinction between arrhythmic and nonarrhythmic death after acute myocardial infarction based on heart rate variability, signal-averaged electrocardiogram, ventricular arrhythmias and left ventricular ejection fraction.
    Hartikainen JE; Malik M; Staunton A; Poloniecki J; Camm AJ
    J Am Coll Cardiol; 1996 Aug; 28(2):296-304. PubMed ID: 8800101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
    Ferrari R;
    Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction.
    Murcia AM; Hennekens CH; Lamas GA; Jiménez-Navarro M; Rouleau JL; Flaker GC; Goldman S; Skali H; Braunwald E; Pfeffer MA
    Arch Intern Med; 2004 Nov; 164(20):2273-9. PubMed ID: 15534166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal and cardiac functions as prognostic factors after revascularization for myocardial infarction].
    Reibis R; Herbstleb J; Kamke W; Dissmann R; Wegscheider K; Völler H
    Dtsch Med Wochenschr; 2007 Jun; 132(23):1259-63. PubMed ID: 17541867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial.
    Ripa RS; Jørgensen E; Wang Y; Thune JJ; Nilsson JC; Søndergaard L; Johnsen HE; Køber L; Grande P; Kastrup J
    Circulation; 2006 Apr; 113(16):1983-92. PubMed ID: 16531621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of ramipril and spironolactone on ventricular remodeling after acute myocardial infarction: randomized and double-blind study].
    Rodríguez JA; Godoy I; Castro P; Quintana JC; Chávez E; Yovanovich J; Corbalán R; Chávez A
    Rev Med Chil; 1997 Jun; 125(6):643-52. PubMed ID: 9515282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of infarct-related artery patency for recovery of left ventricular function and late survival after primary angioplasty for acute myocardial infarction.
    Brodie BR; Stuckey TD; Kissling G; Hansen CJ; Weintraub RA; Kelly TA
    J Am Coll Cardiol; 1996 Aug; 28(2):319-25. PubMed ID: 8800104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of calcium antagonist trials in acute myocardial infarction.
    Roberts R
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III41-7. PubMed ID: 2691141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials.
    Kang S; Yang Y; Li CJ; Gao R
    Clin Ther; 2007 Nov; 29(11):2406-18. PubMed ID: 18158081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
    Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empiric long-term amiodarone prophylaxis following myocardial infarction. A meta-analysis.
    Zarembski DG; Nolan PE; Slack MK; Caruso AC
    Arch Intern Med; 1993 Dec; 153(23):2661-7. PubMed ID: 7504440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging.
    Ruan W; Pan CZ; Huang GQ; Li YL; Ge JB; Shu XH
    Chin Med J (Engl); 2005 Jul; 118(14):1175-81. PubMed ID: 16117862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.